These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1237 related articles for article (PubMed ID: 1517373)

  • 21. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
    Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
    J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Subclinical Cushing's syndrome:analysis of diagnosis and surgical effect].
    Feng C; Li HZ; Xiao H; Yan WG; Li YQ; Xu WF
    Zhonghua Wai Ke Za Zhi; 2007 Dec; 45(24):1691-3. PubMed ID: 18476528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas.
    Valli N; Catargi B; Ronci N; Vergnot V; Leccia F; Ferriere JM; Chene G; Grenier N; Laurent F; Tabarin A
    Eur J Endocrinol; 2001 Apr; 144(4):401-8. PubMed ID: 11275951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Late-night and low-dose dexamethasone-suppressed cortisol in saliva and serum for the diagnosis of cortisol-secreting adrenal adenomas.
    Deutschbein T; Unger N; Hinrichs J; Walz MK; Mann K; Petersenn S
    Eur J Endocrinol; 2009 Nov; 161(5):747-53. PubMed ID: 19726566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism.
    Chiodini I; Morelli V; Salcuni AS; Eller-Vainicher C; Torlontano M; Coletti F; Iorio L; Cuttitta A; Ambrosio A; Vicentini L; Pellegrini F; Copetti M; Beck-Peccoz P; Arosio M; Ambrosi B; Trischitta V; Scillitani A
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2736-45. PubMed ID: 20375210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
    Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL
    J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison between the suppressive effects of dexamethasone and loperamide on cortisol and ACTH secretion in some pathological conditions.
    Bernini GP; Argenio GF; Cerri F; Franchi F
    J Endocrinol Invest; 1994 Nov; 17(10):799-804. PubMed ID: 7699214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Residual adrenocortical function after bilateral adrenalectomy for pituitary-dependent Cushing's syndrome.
    Kemink L; Hermus A; Pieters G; Benraad T; Smals A; Kloppenborg P
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1211-4. PubMed ID: 1331164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasopressin responsiveness of subclinical Cushing's syndrome due to ACTH-independent macronodular adrenocortical hyperplasia.
    Tatsuno I; Uchida D; Tanaka T; Koide H; Shigeta A; Ichikawa T; Sasano H; Saito Y
    Clin Endocrinol (Oxf); 2004 Feb; 60(2):192-200. PubMed ID: 14725680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors.
    Fassnacht M; Tsagarakis S; Terzolo M; Tabarin A; Sahdev A; Newell-Price J; Pelsma I; Marina L; Lorenz K; Bancos I; Arlt W; Dekkers OM
    Eur J Endocrinol; 2023 Jul; 189(1):G1-G42. PubMed ID: 37318239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Food-dependent androgen and cortisol secretion by a gastric inhibitory polypeptide-receptor expressive adrenocortical adenoma leading to hirsutism and subclinical Cushing's syndrome: in vivo and in vitro studies.
    Tsagarakis S; Tsigos C; Vassiliou V; Tsiotra P; Pratsinis H; Kletsas D; Trivizas P; Nikou A; Mavromatis T; Sotsiou F; Raptis S; Thalassinos N
    J Clin Endocrinol Metab; 2001 Feb; 86(2):583-9. PubMed ID: 11158012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subclinical Cushing's syndrome in adrenal incidentalomas.
    Sippel RS; Chen H
    Surg Clin North Am; 2004 Jun; 84(3):875-85. PubMed ID: 15145240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late-night salivary cortisol as a screening test for Cushing's syndrome.
    Raff H; Raff JL; Findling JW
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2681-6. PubMed ID: 9709931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patients with extra-adrenal malignancies and adrenal lesions have similar rates of subclinical hypercortisolism compared with patients with true adrenal incidentalomas.
    Chrisoulidou A; Rakitzi P; Boudina M; Apostolidou-Kiouti F; Poimenidou E; Papanikolaou A; Devlioti A; Rallis G; Pazaitou-Panayiotou K
    Hormones (Athens); 2019 Mar; 18(1):85-89. PubMed ID: 30737657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adrenal incidentalomas showing unilateral concordant visualization by adrenocortical scintigraphy: comparison with adenomas in Cushing's syndrome.
    Tani A; Nakajo M; Tsuchimochi S; Nakabeppu Y; Umanodan T
    Ann Nucl Med; 2000 Jun; 14(3):205-12. PubMed ID: 10921486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study.
    Reznik Y; Lefebvre H; Rohmer V; Charbonnel B; Tabarin A; Rodien P; Lecomte P; Bardet S; Coffin C; Mahoudeau J;
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):311-9. PubMed ID: 15355446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of GH reserve in patients with adrenal incidentalomas and biochemical evidence of subclinical autonomous glucocorticoid hypersecretion.
    Tzanela M; Zianni D; Stylianidou Ch; Karavitaki N; Tsagarakis S; Thalassinos NC
    Clin Endocrinol (Oxf); 2005 May; 62(5):597-602. PubMed ID: 15853831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Aron DC; Raff H; Findling JW
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.